NO20006699L - Forbindelser med veksthormonfrigjörende egenskaper - Google Patents

Forbindelser med veksthormonfrigjörende egenskaper

Info

Publication number
NO20006699L
NO20006699L NO20006699A NO20006699A NO20006699L NO 20006699 L NO20006699 L NO 20006699L NO 20006699 A NO20006699 A NO 20006699A NO 20006699 A NO20006699 A NO 20006699A NO 20006699 L NO20006699 L NO 20006699L
Authority
NO
Norway
Prior art keywords
growth hormone
compounds
hormone releasing
releasing properties
properties
Prior art date
Application number
NO20006699A
Other languages
English (en)
Other versions
NO20006699D0 (no
NO331351B1 (no
Inventor
Bernd Peschke
Stefan Lutz Richter
Thomas Kruse Hansen
Michael Ankersen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of NO20006699D0 publication Critical patent/NO20006699D0/no
Publication of NO20006699L publication Critical patent/NO20006699L/no
Publication of NO331351B1 publication Critical patent/NO331351B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0207—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)4-C(=0), e.g. 'isosters', replacing two amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A61P5/04—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)
  • Peptides Or Proteins (AREA)
NO20006699A 1998-06-30 2000-12-29 Forbindelser med veksthormonfrigjorende egenskaper NO331351B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA199800857 1998-06-30
DKPA199801440 1998-11-09
PCT/DK1999/000368 WO2000001726A1 (en) 1998-06-30 1999-06-29 Compounds with growth hormone releasing properties

Publications (3)

Publication Number Publication Date
NO20006699D0 NO20006699D0 (no) 2000-12-29
NO20006699L true NO20006699L (no) 2001-02-28
NO331351B1 NO331351B1 (no) 2011-12-05

Family

ID=26064788

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20006699A NO331351B1 (no) 1998-06-30 2000-12-29 Forbindelser med veksthormonfrigjorende egenskaper

Country Status (20)

Country Link
EP (1) EP1100824B1 (no)
JP (1) JP4511040B2 (no)
KR (1) KR100907638B1 (no)
CN (1) CN1304424C (no)
AT (1) ATE500269T1 (no)
AU (1) AU771644B2 (no)
BR (1) BRPI9911756B1 (no)
CA (1) CA2334315C (no)
CY (1) CY1111509T1 (no)
CZ (1) CZ299648B6 (no)
DE (1) DE69943239D1 (no)
DK (1) DK1100824T3 (no)
HU (1) HUP0102460A3 (no)
IL (1) IL140044A0 (no)
NO (1) NO331351B1 (no)
PL (1) PL199853B1 (no)
PT (1) PT1100824E (no)
RU (1) RU2298547C2 (no)
TW (1) TW593337B (no)
WO (1) WO2000001726A1 (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005504043A (ja) * 2001-08-10 2005-02-10 パラチン テクノロジーズ インク． 生物学的に活性な金属ペプチド類のペプチド模倣体類
US7476653B2 (en) 2003-06-18 2009-01-13 Tranzyme Pharma, Inc. Macrocyclic modulators of the ghrelin receptor
CA2565324A1 (en) * 2004-03-30 2005-10-20 Sapphire Therapeutics, Inc. Method of reducing c-reactive protein using growth hormone secretagogues
KR20130048793A (ko) 2004-08-12 2013-05-10 헬신 세라퓨틱스 (유.에스.) 인크. 성장 호르몬 분비촉진제를 이용하여 위장관계의 운동성을 촉진하는 방법
WO2006122408A1 (en) 2005-05-18 2006-11-23 Aegera Therapeutics Inc. Bir domain binding compounds
JP2009512719A (ja) 2005-10-25 2009-03-26 アエゲラ セラピューティクス インコーポレイテッド Ｉａｐｂｉｒドメイン結合化合物
CU23558A1 (es) 2006-02-28 2010-07-20 Ct Ingenieria Genetica Biotech Compuestos análogos a los secretagogos peptidicos de la hormona de crecimiento
EP2118080B1 (en) 2007-02-09 2016-08-31 Ocera Therapeutics, Inc. Macrocyclic ghrelin receptor modulators and methods of using the same
CN107382827B (zh) * 2017-04-14 2021-01-01 江苏普莱医药生物技术有限公司 氨基酸衍生物或其药学上可接受的盐及应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT72076A (en) * 1992-12-11 1996-03-28 Merck & Co Inc Process for preparing spiro piperidines and homologs which promote release of growth hormone and pharmaceutical compositions containing them
HUP9802821A3 (en) * 1995-06-22 2000-03-28 Novo Nordisk As Compounds with growth hormone releasing properties
ES2323159T3 (es) * 1995-12-22 2009-07-07 Novo Nordisk A/S Compuestos con propiedades de liberacion de la hormona del crecimiento.
EP0923539B1 (en) * 1996-07-22 2002-06-05 Novo Nordisk A/S Compounds with growth hormone releasing properties
AU7906998A (en) * 1997-06-20 1999-01-04 Novo Nordisk A/S Compounds with growth hormone releasing properties

Also Published As

Publication number Publication date
KR20010053310A (ko) 2001-06-25
CA2334315C (en) 2011-07-26
AU4603899A (en) 2000-01-24
IL140044A0 (en) 2002-02-10
CN1307588A (zh) 2001-08-08
EP1100824B1 (en) 2011-03-02
PL199853B1 (pl) 2008-11-28
NO20006699D0 (no) 2000-12-29
PL345204A1 (en) 2001-12-03
HUP0102460A3 (en) 2001-12-28
RU2298547C2 (ru) 2007-05-10
CZ20004565A3 (en) 2001-06-13
AU771644B2 (en) 2004-04-01
KR100907638B1 (ko) 2009-07-14
NO331351B1 (no) 2011-12-05
CZ299648B6 (cs) 2008-10-01
CY1111509T1 (el) 2015-08-05
ATE500269T1 (de) 2011-03-15
CN1304424C (zh) 2007-03-14
HUP0102460A2 (hu) 2001-11-28
EP1100824A1 (en) 2001-05-23
BRPI9911756B1 (pt) 2016-06-14
DE69943239D1 (de) 2011-04-14
JP4511040B2 (ja) 2010-07-28
JP2002519436A (ja) 2002-07-02
TW593337B (en) 2004-06-21
CA2334315A1 (en) 2000-01-13
PT1100824E (pt) 2011-06-16
DK1100824T3 (da) 2011-06-20
WO2000001726A1 (en) 2000-01-13
BR9911756A (pt) 2001-04-03

Similar Documents

Publication Publication Date Title
IL129592A0 (en) 5-HT1f agonists
CY1109626T1 (el) Ενωσεις με ιδιοτητες αποδεσμευσης αυξητικης ορμονης
IL142900A0 (en) Compositions and methods for the prevention or treatment of cancer and bone loss associated with cancer
YU13301A (sh) Muskarinski agonisti i antagonisti
IL126235A (en) Compounds with growth hormone releasing properties, pharmaceutical compositions comprising them and their use
SE9802937D0 (sv) Novel compounds
DK1100824T3 (da) Forbindelser med væksthormonfrigivende egenskaber
TR200200278T2 (tr) Kalsilitik bileşimler
MXPA02007903A (es) Uso de acido 2-metil-tiazolidina-2, 4-dicarboxilico (2-mtdc) y/o sales fisiologicamente compatibles para tratar y/o prevenir canceres.
GR1003490B (el) Νεες φαρμακευτικες συνθεσεις που περιεχουν αλας παροξετινης
ID25478A (id) Agonis 5-ht1f
NO20012169L (no) Forbindelser med veksthormonfrigjörende egenskaper
NO20003629L (no) Forbindelser med veksthormonfrigjørende egenskaper
UA15363A (uk) Засіб для лікуваhhя відкритих пошкоджеhь

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: HELSINN HEALTHCARE SA, CH

MM1K Lapsed by not paying the annual fees